Risk of serious skin reactions with anaemia drugs

Severe cutaneous adverse reactions can occur in patients treated with erythropoietins, the manufacturers have warned in a letter to healthcare professionals.

Patients should report signs and symptoms of severe cutaneous reactions to erythropoietin treatment immediately. | CNRI/SCIENCE PHOTO LIBRARY
Patients should report signs and symptoms of severe cutaneous reactions to erythropoietin treatment immediately. | CNRI/SCIENCE PHOTO LIBRARY

Severe cutaneous adverse reactions including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported in patients treated with recombinant human erythropoietins (r-HuEPOs). In some cases the reactions have been fatal.

Further information

View erythropoietin drug records

Severe skin reactions are considered to be a very rare class effect of all r-HuEPOs, including darbepoetin alfa (Aranesp), epoetin alfa (Eprex), epoetin beta (NeoRecormon), epoetin zeta (Retacrit) and methoxy polyethylene glycol-epoetin beta (Mircera).

The reactions have been more severe with long-acting r-HuEPOs such as methoxy polyethylene glycol-epoetin beta.

Patients starting treatment with an r-HuEPO hould be instructed to their doctor immediately and stop epoetin treatment if they develop the following signs and symptoms of severe skin reactions:

  • Widespread rash with reddening and blistering of the skin and oral mucosa, eyes, nose, throat, or genital area, which follow flu-like symptoms including fever, tiredness, muscle and joint pain. This often leads to peeling and shedding of the affected skin which looks like a severe burn.

If a patient develops a severe cutaneous adverse reaction such as SJS or TEN which is considered to be related to the use of an r-HuEPO, the patient must never be given an r-HuEPO again.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

More from intelog

Review patients soon after starting opioids, says updated chronic pain guidance

Review patients soon after starting opioids, says updated chronic pain guidance

Revised chronic pain guidance from the Scottish Intercollegiate...

Contraceptive shortages reported by manufacturers

Contraceptive shortages reported by manufacturers

Shortages of several contraceptives, including combined,...

Hormone Replacement Therapy (HRT)

Hormone Replacement Therapy (HRT)

Hormone doses and costs of HRT preparations.

Drug shortages - live tracker

Drug shortages - live tracker

Added: FemSeven Sequi and FemSeven Conti.
Use...